nodes	percent_of_prediction	percent_of_DWPC	metapath
Pethidine—CYP2D6—Vinorelbine—ovarian cancer	0.034	0.212	CbGbCtD
Pethidine—CYP3A4—Topotecan—ovarian cancer	0.0307	0.192	CbGbCtD
Pethidine—CYP2B6—Doxorubicin—ovarian cancer	0.0266	0.166	CbGbCtD
Pethidine—Etomidate—SLC2A1—ovarian cancer	0.0228	0.911	CrCbGaD
Pethidine—CYP3A4—Vinorelbine—ovarian cancer	0.0216	0.135	CbGbCtD
Pethidine—CYP3A4—Paclitaxel—ovarian cancer	0.0152	0.0948	CbGbCtD
Pethidine—CYP2D6—Doxorubicin—ovarian cancer	0.0129	0.0804	CbGbCtD
Pethidine—CYP3A4—Docetaxel—ovarian cancer	0.011	0.0686	CbGbCtD
Pethidine—CYP3A4—Doxorubicin—ovarian cancer	0.00818	0.0511	CbGbCtD
Pethidine—Phlebitis—Paclitaxel—ovarian cancer	0.0027	0.00531	CcSEcCtD
Pethidine—Paralysis—Epirubicin—ovarian cancer	0.00263	0.00519	CcSEcCtD
Pethidine—Tremor—Chlorambucil—ovarian cancer	0.00256	0.00504	CcSEcCtD
Pethidine—Flushing—Melphalan—ovarian cancer	0.00254	0.005	CcSEcCtD
Pethidine—Agitation—Chlorambucil—ovarian cancer	0.00251	0.00494	CcSEcCtD
Pethidine—Visual disturbance—Paclitaxel—ovarian cancer	0.00245	0.00483	CcSEcCtD
Pethidine—Paralysis—Doxorubicin—ovarian cancer	0.00244	0.0048	CcSEcCtD
Pethidine—Lightheadedness—Docetaxel—ovarian cancer	0.00243	0.00478	CcSEcCtD
Pethidine—Convulsion—Chlorambucil—ovarian cancer	0.00237	0.00466	CcSEcCtD
Pethidine—Muscle spasms—Topotecan—ovarian cancer	0.00234	0.00461	CcSEcCtD
Pethidine—Phlebitis—Docetaxel—ovarian cancer	0.00229	0.0045	CcSEcCtD
Pethidine—Confusional state—Chlorambucil—ovarian cancer	0.00225	0.00443	CcSEcCtD
Pethidine—Injection site pain—Epirubicin—ovarian cancer	0.00224	0.00442	CcSEcCtD
Pethidine—Flushing—Vinorelbine—ovarian cancer	0.00222	0.00437	CcSEcCtD
Pethidine—Levomilnacipran—ABCB1—ovarian cancer	0.00221	0.0885	CrCbGaD
Pethidine—Cardiac arrest—Paclitaxel—ovarian cancer	0.00221	0.00435	CcSEcCtD
Pethidine—Mood swings—Paclitaxel—ovarian cancer	0.0022	0.00434	CcSEcCtD
Pethidine—Delirium—Epirubicin—ovarian cancer	0.00213	0.00419	CcSEcCtD
Pethidine—Anorexia—Chlorambucil—ovarian cancer	0.00212	0.00419	CcSEcCtD
Pethidine—Orthostatic hypotension—Paclitaxel—ovarian cancer	0.00212	0.00418	CcSEcCtD
Pethidine—Vasodilation—Epirubicin—ovarian cancer	0.00208	0.0041	CcSEcCtD
Pethidine—Vasodilation procedure—Epirubicin—ovarian cancer	0.00208	0.0041	CcSEcCtD
Pethidine—Erythema—Vinorelbine—ovarian cancer	0.00208	0.0041	CcSEcCtD
Pethidine—Visual disturbance—Docetaxel—ovarian cancer	0.00208	0.00409	CcSEcCtD
Pethidine—Injection site pain—Doxorubicin—ovarian cancer	0.00207	0.00409	CcSEcCtD
Pethidine—Convulsion—Melphalan—ovarian cancer	0.00206	0.00406	CcSEcCtD
Pethidine—Anaphylactic shock—Topotecan—ovarian cancer	0.00198	0.00391	CcSEcCtD
Pethidine—Delirium—Doxorubicin—ovarian cancer	0.00197	0.00388	CcSEcCtD
Pethidine—Dyskinesia—Epirubicin—ovarian cancer	0.00195	0.00384	CcSEcCtD
Pethidine—Oedema—Melphalan—ovarian cancer	0.00194	0.00383	CcSEcCtD
Pethidine—Anaphylactic shock—Melphalan—ovarian cancer	0.00194	0.00383	CcSEcCtD
Pethidine—Decreased appetite—Chlorambucil—ovarian cancer	0.00194	0.00382	CcSEcCtD
Pethidine—Vasodilation—Doxorubicin—ovarian cancer	0.00193	0.0038	CcSEcCtD
Pethidine—Vasodilation procedure—Doxorubicin—ovarian cancer	0.00193	0.0038	CcSEcCtD
Pethidine—Hyperhidrosis—Topotecan—ovarian cancer	0.00192	0.00378	CcSEcCtD
Pethidine—Tachycardia—Melphalan—ovarian cancer	0.0019	0.00374	CcSEcCtD
Pethidine—Anorexia—Topotecan—ovarian cancer	0.00189	0.00373	CcSEcCtD
Pethidine—Vertigo—Vinorelbine—ovarian cancer	0.00187	0.00368	CcSEcCtD
Pethidine—Coordination abnormal—Epirubicin—ovarian cancer	0.00186	0.00367	CcSEcCtD
Pethidine—Anorexia—Melphalan—ovarian cancer	0.00185	0.00365	CcSEcCtD
Pethidine—Palpitations—Vinorelbine—ovarian cancer	0.00184	0.00362	CcSEcCtD
Pethidine—Feeling abnormal—Chlorambucil—ovarian cancer	0.00184	0.00362	CcSEcCtD
Pethidine—Hypotension—Melphalan—ovarian cancer	0.00182	0.00358	CcSEcCtD
Pethidine—Dyskinesia—Doxorubicin—ovarian cancer	0.0018	0.00355	CcSEcCtD
Pethidine—Orthostatic hypotension—Docetaxel—ovarian cancer	0.0018	0.00354	CcSEcCtD
Pethidine—Hypertension—Vinorelbine—ovarian cancer	0.0018	0.00354	CcSEcCtD
Pethidine—Urticaria—Chlorambucil—ovarian cancer	0.00177	0.00349	CcSEcCtD
Pethidine—Decreased appetite—Topotecan—ovarian cancer	0.00173	0.0034	CcSEcCtD
Pethidine—Coordination abnormal—Doxorubicin—ovarian cancer	0.00172	0.0034	CcSEcCtD
Pethidine—Anaphylactic shock—Vinorelbine—ovarian cancer	0.0017	0.00334	CcSEcCtD
Pethidine—Constipation—Topotecan—ovarian cancer	0.0017	0.00334	CcSEcCtD
Pethidine—Decreased appetite—Melphalan—ovarian cancer	0.00169	0.00333	CcSEcCtD
Pethidine—Coma—Epirubicin—ovarian cancer	0.00167	0.00329	CcSEcCtD
Pethidine—Tachycardia—Vinorelbine—ovarian cancer	0.00166	0.00326	CcSEcCtD
Pethidine—Hypersensitivity—Chlorambucil—ovarian cancer	0.00164	0.00324	CcSEcCtD
Pethidine—Bradycardia—Paclitaxel—ovarian cancer	0.00164	0.00322	CcSEcCtD
Pethidine—Feeling abnormal—Topotecan—ovarian cancer	0.00164	0.00322	CcSEcCtD
Pethidine—Anorexia—Vinorelbine—ovarian cancer	0.00162	0.00319	CcSEcCtD
Pethidine—Asthenia—Chlorambucil—ovarian cancer	0.0016	0.00315	CcSEcCtD
Pethidine—Hypotension—Vinorelbine—ovarian cancer	0.00159	0.00313	CcSEcCtD
Pethidine—Pruritus—Chlorambucil—ovarian cancer	0.00158	0.00311	CcSEcCtD
Pethidine—Urticaria—Topotecan—ovarian cancer	0.00158	0.00311	CcSEcCtD
Pethidine—Visual impairment—Paclitaxel—ovarian cancer	0.00155	0.00305	CcSEcCtD
Pethidine—Coma—Doxorubicin—ovarian cancer	0.00155	0.00305	CcSEcCtD
Pethidine—Urticaria—Melphalan—ovarian cancer	0.00154	0.00304	CcSEcCtD
Pethidine—Phlebitis—Epirubicin—ovarian cancer	0.00154	0.00304	CcSEcCtD
Pethidine—Flushing—Paclitaxel—ovarian cancer	0.00149	0.00294	CcSEcCtD
Pethidine—Decreased appetite—Vinorelbine—ovarian cancer	0.00148	0.00291	CcSEcCtD
Pethidine—Hypersensitivity—Topotecan—ovarian cancer	0.00146	0.00288	CcSEcCtD
Pethidine—Constipation—Vinorelbine—ovarian cancer	0.00145	0.00286	CcSEcCtD
Pethidine—Hypersensitivity—Melphalan—ovarian cancer	0.00143	0.00282	CcSEcCtD
Pethidine—Phlebitis—Doxorubicin—ovarian cancer	0.00143	0.00281	CcSEcCtD
Pethidine—Asthenia—Topotecan—ovarian cancer	0.00142	0.0028	CcSEcCtD
Pethidine—Vomiting—Chlorambucil—ovarian cancer	0.00142	0.00279	CcSEcCtD
Pethidine—Pruritus—Topotecan—ovarian cancer	0.0014	0.00277	CcSEcCtD
Pethidine—Erythema—Paclitaxel—ovarian cancer	0.0014	0.00276	CcSEcCtD
Pethidine—Feeling abnormal—Vinorelbine—ovarian cancer	0.0014	0.00276	CcSEcCtD
Pethidine—Asthenia—Melphalan—ovarian cancer	0.00139	0.00275	CcSEcCtD
Pethidine—Pruritus—Melphalan—ovarian cancer	0.00137	0.00271	CcSEcCtD
Pethidine—Urticaria—Vinorelbine—ovarian cancer	0.00135	0.00266	CcSEcCtD
Pethidine—Muscle spasms—Paclitaxel—ovarian cancer	0.00135	0.00265	CcSEcCtD
Pethidine—Nausea—Chlorambucil—ovarian cancer	0.00132	0.00261	CcSEcCtD
Pethidine—Visual impairment—Docetaxel—ovarian cancer	0.00131	0.00259	CcSEcCtD
Pethidine—Dizziness—Topotecan—ovarian cancer	0.00131	0.00259	CcSEcCtD
Pethidine—Tremor—Paclitaxel—ovarian cancer	0.00131	0.00258	CcSEcCtD
Pethidine—Affect lability—Epirubicin—ovarian cancer	0.00131	0.00258	CcSEcCtD
Pethidine—Agitation—Paclitaxel—ovarian cancer	0.00129	0.00253	CcSEcCtD
Pethidine—Flushing—Docetaxel—ovarian cancer	0.00126	0.00249	CcSEcCtD
Pethidine—Cardiac arrest—Epirubicin—ovarian cancer	0.00126	0.00249	CcSEcCtD
Pethidine—Vomiting—Topotecan—ovarian cancer	0.00126	0.00249	CcSEcCtD
Pethidine—Mood swings—Epirubicin—ovarian cancer	0.00126	0.00248	CcSEcCtD
Pethidine—Vertigo—Paclitaxel—ovarian cancer	0.00126	0.00248	CcSEcCtD
Pethidine—Syncope—Paclitaxel—ovarian cancer	0.00125	0.00247	CcSEcCtD
Pethidine—Rash—Topotecan—ovarian cancer	0.00125	0.00247	CcSEcCtD
Pethidine—Hypersensitivity—Vinorelbine—ovarian cancer	0.00125	0.00246	CcSEcCtD
Pethidine—Dermatitis—Topotecan—ovarian cancer	0.00125	0.00246	CcSEcCtD
Pethidine—Headache—Topotecan—ovarian cancer	0.00124	0.00245	CcSEcCtD
Pethidine—Palpitations—Paclitaxel—ovarian cancer	0.00124	0.00244	CcSEcCtD
Pethidine—Vomiting—Melphalan—ovarian cancer	0.00124	0.00243	CcSEcCtD
Pethidine—Loss of consciousness—Paclitaxel—ovarian cancer	0.00123	0.00242	CcSEcCtD
Pethidine—Rash—Melphalan—ovarian cancer	0.00123	0.00241	CcSEcCtD
Pethidine—Dermatitis—Melphalan—ovarian cancer	0.00122	0.00241	CcSEcCtD
Pethidine—Asthenia—Vinorelbine—ovarian cancer	0.00122	0.0024	CcSEcCtD
Pethidine—Orthostatic hypotension—Epirubicin—ovarian cancer	0.00121	0.00239	CcSEcCtD
Pethidine—Convulsion—Paclitaxel—ovarian cancer	0.00121	0.00239	CcSEcCtD
Pethidine—Affect lability—Doxorubicin—ovarian cancer	0.00121	0.00238	CcSEcCtD
Pethidine—Hypertension—Paclitaxel—ovarian cancer	0.00121	0.00238	CcSEcCtD
Pethidine—Pruritus—Vinorelbine—ovarian cancer	0.0012	0.00237	CcSEcCtD
Pethidine—Anxiety—Paclitaxel—ovarian cancer	0.00119	0.00234	CcSEcCtD
Pethidine—Erythema—Docetaxel—ovarian cancer	0.00119	0.00234	CcSEcCtD
Pethidine—Nausea—Topotecan—ovarian cancer	0.00118	0.00232	CcSEcCtD
Pethidine—Cardiac arrest—Doxorubicin—ovarian cancer	0.00117	0.0023	CcSEcCtD
Pethidine—Dry mouth—Paclitaxel—ovarian cancer	0.00116	0.00229	CcSEcCtD
Pethidine—Mood swings—Doxorubicin—ovarian cancer	0.00116	0.00229	CcSEcCtD
Pethidine—Nausea—Melphalan—ovarian cancer	0.00115	0.00227	CcSEcCtD
Pethidine—Confusional state—Paclitaxel—ovarian cancer	0.00115	0.00227	CcSEcCtD
Pethidine—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00114	0.00225	CcSEcCtD
Pethidine—Oedema—Paclitaxel—ovarian cancer	0.00114	0.00225	CcSEcCtD
Pethidine—Muscle spasms—Docetaxel—ovarian cancer	0.00114	0.00225	CcSEcCtD
Pethidine—Shock—Paclitaxel—ovarian cancer	0.00112	0.00221	CcSEcCtD
Pethidine—Dizziness—Vinorelbine—ovarian cancer	0.00112	0.00221	CcSEcCtD
Pethidine—Orthostatic hypotension—Doxorubicin—ovarian cancer	0.00112	0.00221	CcSEcCtD
Pethidine—Tachycardia—Paclitaxel—ovarian cancer	0.00111	0.0022	CcSEcCtD
Pethidine—Hyperhidrosis—Paclitaxel—ovarian cancer	0.0011	0.00217	CcSEcCtD
Pethidine—Anorexia—Paclitaxel—ovarian cancer	0.00109	0.00214	CcSEcCtD
Pethidine—Vomiting—Vinorelbine—ovarian cancer	0.00108	0.00213	CcSEcCtD
Pethidine—Rash—Vinorelbine—ovarian cancer	0.00107	0.00211	CcSEcCtD
Pethidine—Dermatitis—Vinorelbine—ovarian cancer	0.00107	0.00211	CcSEcCtD
Pethidine—Hypotension—Paclitaxel—ovarian cancer	0.00107	0.0021	CcSEcCtD
Pethidine—Headache—Vinorelbine—ovarian cancer	0.00106	0.0021	CcSEcCtD
Pethidine—Syncope—Docetaxel—ovarian cancer	0.00106	0.0021	CcSEcCtD
Pethidine—Palpitations—Docetaxel—ovarian cancer	0.00105	0.00206	CcSEcCtD
Pethidine—Loss of consciousness—Docetaxel—ovarian cancer	0.00104	0.00205	CcSEcCtD
Pethidine—Insomnia—Paclitaxel—ovarian cancer	0.00103	0.00203	CcSEcCtD
Pethidine—Convulsion—Docetaxel—ovarian cancer	0.00103	0.00202	CcSEcCtD
Pethidine—Hypertension—Docetaxel—ovarian cancer	0.00102	0.00202	CcSEcCtD
Pethidine—Drowsiness—Epirubicin—ovarian cancer	0.00102	0.00202	CcSEcCtD
Pethidine—Somnolence—Paclitaxel—ovarian cancer	0.00102	0.002	CcSEcCtD
Pethidine—Nausea—Vinorelbine—ovarian cancer	0.00101	0.00199	CcSEcCtD
Pethidine—Decreased appetite—Paclitaxel—ovarian cancer	0.000993	0.00196	CcSEcCtD
Pethidine—Dry mouth—Docetaxel—ovarian cancer	0.000987	0.00195	CcSEcCtD
Pethidine—Sweating—Epirubicin—ovarian cancer	0.000981	0.00193	CcSEcCtD
Pethidine—Constipation—Paclitaxel—ovarian cancer	0.000976	0.00192	CcSEcCtD
Pethidine—Confusional state—Docetaxel—ovarian cancer	0.000976	0.00192	CcSEcCtD
Pethidine—Anaphylactic shock—Docetaxel—ovarian cancer	0.000968	0.00191	CcSEcCtD
Pethidine—Oedema—Docetaxel—ovarian cancer	0.000968	0.00191	CcSEcCtD
Pethidine—Shock—Docetaxel—ovarian cancer	0.000952	0.00188	CcSEcCtD
Pethidine—Drowsiness—Doxorubicin—ovarian cancer	0.000947	0.00187	CcSEcCtD
Pethidine—Tachycardia—Docetaxel—ovarian cancer	0.000945	0.00186	CcSEcCtD
Pethidine—Feeling abnormal—Paclitaxel—ovarian cancer	0.000941	0.00185	CcSEcCtD
Pethidine—Bradycardia—Epirubicin—ovarian cancer	0.000935	0.00184	CcSEcCtD
Pethidine—Anorexia—Docetaxel—ovarian cancer	0.000923	0.00182	CcSEcCtD
Pethidine—Sweating—Doxorubicin—ovarian cancer	0.000908	0.00179	CcSEcCtD
Pethidine—Urticaria—Paclitaxel—ovarian cancer	0.000907	0.00179	CcSEcCtD
Pethidine—Hypotension—Docetaxel—ovarian cancer	0.000904	0.00178	CcSEcCtD
Pethidine—Visual impairment—Epirubicin—ovarian cancer	0.000885	0.00174	CcSEcCtD
Pethidine—Insomnia—Docetaxel—ovarian cancer	0.000875	0.00172	CcSEcCtD
Pethidine—Bradycardia—Doxorubicin—ovarian cancer	0.000866	0.00171	CcSEcCtD
Pethidine—Somnolence—Docetaxel—ovarian cancer	0.00086	0.0017	CcSEcCtD
Pethidine—Flushing—Epirubicin—ovarian cancer	0.000853	0.00168	CcSEcCtD
Pethidine—Decreased appetite—Docetaxel—ovarian cancer	0.000841	0.00166	CcSEcCtD
Pethidine—Hypersensitivity—Paclitaxel—ovarian cancer	0.000841	0.00166	CcSEcCtD
Pethidine—Constipation—Docetaxel—ovarian cancer	0.000828	0.00163	CcSEcCtD
Pethidine—Visual impairment—Doxorubicin—ovarian cancer	0.000819	0.00161	CcSEcCtD
Pethidine—Asthenia—Paclitaxel—ovarian cancer	0.000819	0.00161	CcSEcCtD
Pethidine—Pruritus—Paclitaxel—ovarian cancer	0.000808	0.00159	CcSEcCtD
Pethidine—Erythema—Epirubicin—ovarian cancer	0.0008	0.00158	CcSEcCtD
Pethidine—Feeling abnormal—Docetaxel—ovarian cancer	0.000798	0.00157	CcSEcCtD
Pethidine—Flushing—Doxorubicin—ovarian cancer	0.000789	0.00155	CcSEcCtD
Pethidine—Muscle spasms—Epirubicin—ovarian cancer	0.000769	0.00151	CcSEcCtD
Pethidine—Dizziness—Paclitaxel—ovarian cancer	0.000755	0.00149	CcSEcCtD
Pethidine—Erythema—Doxorubicin—ovarian cancer	0.00074	0.00146	CcSEcCtD
Pethidine—Agitation—Epirubicin—ovarian cancer	0.000735	0.00145	CcSEcCtD
Pethidine—Vomiting—Paclitaxel—ovarian cancer	0.000726	0.00143	CcSEcCtD
Pethidine—Rash—Paclitaxel—ovarian cancer	0.00072	0.00142	CcSEcCtD
Pethidine—Dermatitis—Paclitaxel—ovarian cancer	0.000719	0.00142	CcSEcCtD
Pethidine—Vertigo—Epirubicin—ovarian cancer	0.000719	0.00142	CcSEcCtD
Pethidine—Syncope—Epirubicin—ovarian cancer	0.000717	0.00141	CcSEcCtD
Pethidine—Headache—Paclitaxel—ovarian cancer	0.000715	0.00141	CcSEcCtD
Pethidine—Hypersensitivity—Docetaxel—ovarian cancer	0.000713	0.0014	CcSEcCtD
Pethidine—Muscle spasms—Doxorubicin—ovarian cancer	0.000712	0.0014	CcSEcCtD
Pethidine—Palpitations—Epirubicin—ovarian cancer	0.000707	0.00139	CcSEcCtD
Pethidine—Loss of consciousness—Epirubicin—ovarian cancer	0.000703	0.00138	CcSEcCtD
Pethidine—Asthenia—Docetaxel—ovarian cancer	0.000694	0.00137	CcSEcCtD
Pethidine—Convulsion—Epirubicin—ovarian cancer	0.000693	0.00137	CcSEcCtD
Pethidine—Hypertension—Epirubicin—ovarian cancer	0.000691	0.00136	CcSEcCtD
Pethidine—Pruritus—Docetaxel—ovarian cancer	0.000685	0.00135	CcSEcCtD
Pethidine—Agitation—Doxorubicin—ovarian cancer	0.00068	0.00134	CcSEcCtD
Pethidine—Anxiety—Epirubicin—ovarian cancer	0.000679	0.00134	CcSEcCtD
Pethidine—Nausea—Paclitaxel—ovarian cancer	0.000678	0.00134	CcSEcCtD
Pethidine—Dry mouth—Epirubicin—ovarian cancer	0.000666	0.00131	CcSEcCtD
Pethidine—Vertigo—Doxorubicin—ovarian cancer	0.000665	0.00131	CcSEcCtD
Pethidine—Syncope—Doxorubicin—ovarian cancer	0.000664	0.00131	CcSEcCtD
Pethidine—Confusional state—Epirubicin—ovarian cancer	0.000658	0.0013	CcSEcCtD
Pethidine—Palpitations—Doxorubicin—ovarian cancer	0.000654	0.00129	CcSEcCtD
Pethidine—Anaphylactic shock—Epirubicin—ovarian cancer	0.000653	0.00129	CcSEcCtD
Pethidine—Oedema—Epirubicin—ovarian cancer	0.000653	0.00129	CcSEcCtD
Pethidine—Loss of consciousness—Doxorubicin—ovarian cancer	0.00065	0.00128	CcSEcCtD
Pethidine—Shock—Epirubicin—ovarian cancer	0.000642	0.00127	CcSEcCtD
Pethidine—Convulsion—Doxorubicin—ovarian cancer	0.000641	0.00126	CcSEcCtD
Pethidine—Dizziness—Docetaxel—ovarian cancer	0.00064	0.00126	CcSEcCtD
Pethidine—Hypertension—Doxorubicin—ovarian cancer	0.000639	0.00126	CcSEcCtD
Pethidine—Tachycardia—Epirubicin—ovarian cancer	0.000637	0.00126	CcSEcCtD
Pethidine—Hyperhidrosis—Epirubicin—ovarian cancer	0.000631	0.00124	CcSEcCtD
Pethidine—Anxiety—Doxorubicin—ovarian cancer	0.000628	0.00124	CcSEcCtD
Pethidine—Anorexia—Epirubicin—ovarian cancer	0.000622	0.00123	CcSEcCtD
Pethidine—Dry mouth—Doxorubicin—ovarian cancer	0.000616	0.00121	CcSEcCtD
Pethidine—Vomiting—Docetaxel—ovarian cancer	0.000615	0.00121	CcSEcCtD
Pethidine—Rash—Docetaxel—ovarian cancer	0.00061	0.0012	CcSEcCtD
Pethidine—Hypotension—Epirubicin—ovarian cancer	0.00061	0.0012	CcSEcCtD
Pethidine—Dermatitis—Docetaxel—ovarian cancer	0.00061	0.0012	CcSEcCtD
Pethidine—Confusional state—Doxorubicin—ovarian cancer	0.000609	0.0012	CcSEcCtD
Pethidine—Headache—Docetaxel—ovarian cancer	0.000606	0.00119	CcSEcCtD
Pethidine—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000604	0.00119	CcSEcCtD
Pethidine—Oedema—Doxorubicin—ovarian cancer	0.000604	0.00119	CcSEcCtD
Pethidine—Shock—Doxorubicin—ovarian cancer	0.000594	0.00117	CcSEcCtD
Pethidine—Insomnia—Epirubicin—ovarian cancer	0.00059	0.00116	CcSEcCtD
Pethidine—Tachycardia—Doxorubicin—ovarian cancer	0.00059	0.00116	CcSEcCtD
Pethidine—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000584	0.00115	CcSEcCtD
Pethidine—Somnolence—Epirubicin—ovarian cancer	0.00058	0.00114	CcSEcCtD
Pethidine—Anorexia—Doxorubicin—ovarian cancer	0.000576	0.00113	CcSEcCtD
Pethidine—Nausea—Docetaxel—ovarian cancer	0.000575	0.00113	CcSEcCtD
Pethidine—Decreased appetite—Epirubicin—ovarian cancer	0.000567	0.00112	CcSEcCtD
Pethidine—Hypotension—Doxorubicin—ovarian cancer	0.000564	0.00111	CcSEcCtD
Pethidine—Constipation—Epirubicin—ovarian cancer	0.000558	0.0011	CcSEcCtD
Pethidine—Insomnia—Doxorubicin—ovarian cancer	0.000546	0.00108	CcSEcCtD
Pethidine—Feeling abnormal—Epirubicin—ovarian cancer	0.000538	0.00106	CcSEcCtD
Pethidine—Somnolence—Doxorubicin—ovarian cancer	0.000537	0.00106	CcSEcCtD
Pethidine—Decreased appetite—Doxorubicin—ovarian cancer	0.000525	0.00103	CcSEcCtD
Pethidine—Urticaria—Epirubicin—ovarian cancer	0.000519	0.00102	CcSEcCtD
Pethidine—Constipation—Doxorubicin—ovarian cancer	0.000517	0.00102	CcSEcCtD
Pethidine—Feeling abnormal—Doxorubicin—ovarian cancer	0.000498	0.000981	CcSEcCtD
Pethidine—Hypersensitivity—Epirubicin—ovarian cancer	0.000481	0.000948	CcSEcCtD
Pethidine—Urticaria—Doxorubicin—ovarian cancer	0.00048	0.000945	CcSEcCtD
Pethidine—Asthenia—Epirubicin—ovarian cancer	0.000468	0.000923	CcSEcCtD
Pethidine—Pruritus—Epirubicin—ovarian cancer	0.000462	0.00091	CcSEcCtD
Pethidine—Hypersensitivity—Doxorubicin—ovarian cancer	0.000445	0.000877	CcSEcCtD
Pethidine—Asthenia—Doxorubicin—ovarian cancer	0.000433	0.000854	CcSEcCtD
Pethidine—Dizziness—Epirubicin—ovarian cancer	0.000432	0.00085	CcSEcCtD
Pethidine—Pruritus—Doxorubicin—ovarian cancer	0.000427	0.000842	CcSEcCtD
Pethidine—Vomiting—Epirubicin—ovarian cancer	0.000415	0.000818	CcSEcCtD
Pethidine—Rash—Epirubicin—ovarian cancer	0.000412	0.000811	CcSEcCtD
Pethidine—Dermatitis—Epirubicin—ovarian cancer	0.000411	0.00081	CcSEcCtD
Pethidine—Headache—Epirubicin—ovarian cancer	0.000409	0.000806	CcSEcCtD
Pethidine—Dizziness—Doxorubicin—ovarian cancer	0.000399	0.000787	CcSEcCtD
Pethidine—Nausea—Epirubicin—ovarian cancer	0.000388	0.000764	CcSEcCtD
Pethidine—Vomiting—Doxorubicin—ovarian cancer	0.000384	0.000757	CcSEcCtD
Pethidine—Rash—Doxorubicin—ovarian cancer	0.000381	0.00075	CcSEcCtD
Pethidine—Dermatitis—Doxorubicin—ovarian cancer	0.00038	0.00075	CcSEcCtD
Pethidine—Headache—Doxorubicin—ovarian cancer	0.000378	0.000745	CcSEcCtD
Pethidine—Nausea—Doxorubicin—ovarian cancer	0.000359	0.000707	CcSEcCtD
Pethidine—SLC6A3—Neuronal System—MAPK1—ovarian cancer	0.000103	0.000336	CbGpPWpGaD
Pethidine—ALB—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000103	0.000334	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000102	0.000332	CbGpPWpGaD
Pethidine—ALB—Hemostasis—SOD1—ovarian cancer	0.000101	0.00033	CbGpPWpGaD
Pethidine—ALB—Hemostasis—PPP2R1A—ovarian cancer	0.000101	0.000328	CbGpPWpGaD
Pethidine—ALB—Platelet activation, signaling and aggregation—PIK3CB—ovarian cancer	0.0001	0.000327	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PGR—ovarian cancer	0.0001	0.000326	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—YAP1—ovarian cancer	9.7e-05	0.000316	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CYTB—ovarian cancer	9.51e-05	0.00031	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—XIAP—ovarian cancer	9.5e-05	0.000309	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—PIK3CG—ovarian cancer	9.43e-05	0.000307	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PARP1—ovarian cancer	9.32e-05	0.000303	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	9.3e-05	0.000303	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—SMARCA4—ovarian cancer	9.26e-05	0.000301	CbGpPWpGaD
Pethidine—ALB—Metabolism—BRIP1—ovarian cancer	9.26e-05	0.000301	CbGpPWpGaD
Pethidine—ALB—Metabolism—PPP1CC—ovarian cancer	9.26e-05	0.000301	CbGpPWpGaD
Pethidine—ALB—Platelet activation, signaling and aggregation—IL2—ovarian cancer	9.22e-05	0.0003	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—HRAS—ovarian cancer	9.18e-05	0.000299	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—EREG—ovarian cancer	9.04e-05	0.000294	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—HRAS—ovarian cancer	8.95e-05	0.000291	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—IL6ST—ovarian cancer	8.91e-05	0.00029	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—NME2—ovarian cancer	8.88e-05	0.000289	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—IL6—ovarian cancer	8.78e-05	0.000286	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CYTB—ovarian cancer	8.75e-05	0.000285	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—PIK3CG—ovarian cancer	8.56e-05	0.000279	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—IL6—ovarian cancer	8.56e-05	0.000279	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PGR—ovarian cancer	8.47e-05	0.000276	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PPP1CC—ovarian cancer	8.31e-05	0.000271	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—BRIP1—ovarian cancer	8.31e-05	0.000271	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—PIK3CD—ovarian cancer	8.29e-05	0.00027	CbGpPWpGaD
Pethidine—SLC6A3—Neuronal System—HRAS—ovarian cancer	8.28e-05	0.000269	CbGpPWpGaD
Pethidine—ALB—Transmembrane transport of small molecules—ABCB1—ovarian cancer	8.11e-05	0.000264	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—AKT1—ovarian cancer	8.1e-05	0.000264	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—PIK3CG—ovarian cancer	7.97e-05	0.000259	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—AKT1—ovarian cancer	7.9e-05	0.000257	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PARP1—ovarian cancer	7.88e-05	0.000256	CbGpPWpGaD
Pethidine—ALB—Platelet activation, signaling and aggregation—VEGFA—ovarian cancer	7.83e-05	0.000255	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PPP1CC—ovarian cancer	7.65e-05	0.000249	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—BRIP1—ovarian cancer	7.65e-05	0.000249	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PPP2R1A—ovarian cancer	7.56e-05	0.000246	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—IL6ST—ovarian cancer	7.53e-05	0.000245	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—PIK3CD—ovarian cancer	7.53e-05	0.000245	CbGpPWpGaD
Pethidine—ALB—Hemostasis—CAV1—ovarian cancer	7.41e-05	0.000241	CbGpPWpGaD
Pethidine—ALB—Platelet activation, signaling and aggregation—MAPK3—ovarian cancer	7.41e-05	0.000241	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—YAP1—ovarian cancer	7.38e-05	0.00024	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—PIK3CG—ovarian cancer	7.24e-05	0.000236	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—PIK3CB—ovarian cancer	7.23e-05	0.000235	CbGpPWpGaD
Pethidine—ALB—Platelet activation, signaling and aggregation—MAPK1—ovarian cancer	7.05e-05	0.000229	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—PIK3CD—ovarian cancer	7.01e-05	0.000228	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—CXCL8—ovarian cancer	6.94e-05	0.000226	CbGpPWpGaD
Pethidine—ALB—Hemostasis—PIK3CG—ovarian cancer	6.75e-05	0.00022	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	6.75e-05	0.00022	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—IL2—ovarian cancer	6.64e-05	0.000216	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—PIK3CB—ovarian cancer	6.56e-05	0.000214	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PPP2R1A—ovarian cancer	6.39e-05	0.000208	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—PIK3CD—ovarian cancer	6.36e-05	0.000207	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—CXCL8—ovarian cancer	6.31e-05	0.000205	CbGpPWpGaD
Pethidine—ALB—Metabolism—YAP1—ovarian cancer	6.21e-05	0.000202	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	6.15e-05	0.0002	CbGpPWpGaD
Pethidine—ALB—Platelet activation, signaling and aggregation—PIK3CA—ovarian cancer	6.12e-05	0.000199	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—PIK3CB—ovarian cancer	6.11e-05	0.000199	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	6.06e-05	0.000197	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—IL2—ovarian cancer	6.03e-05	0.000196	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—FASN—ovarian cancer	6.02e-05	0.000196	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—TERT—ovarian cancer	6e-05	0.000195	CbGpPWpGaD
Pethidine—ALB—Hemostasis—PIK3CD—ovarian cancer	5.94e-05	0.000193	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—SLC5A5—ovarian cancer	5.92e-05	0.000193	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—CXCL8—ovarian cancer	5.87e-05	0.000191	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CYTB—ovarian cancer	5.72e-05	0.000186	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—SLC2A1—ovarian cancer	5.71e-05	0.000186	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—IL2—ovarian cancer	5.61e-05	0.000183	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—YAP1—ovarian cancer	5.58e-05	0.000181	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CAV1—ovarian cancer	5.55e-05	0.000181	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—PIK3CB—ovarian cancer	5.55e-05	0.00018	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	5.52e-05	0.00018	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—CYP1B1—ovarian cancer	5.48e-05	0.000178	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	5.4e-05	0.000176	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—ESR1—ovarian cancer	5.35e-05	0.000174	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—CXCL8—ovarian cancer	5.33e-05	0.000173	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—IL6ST—ovarian cancer	5.27e-05	0.000171	CbGpPWpGaD
Pethidine—ALB—Hemostasis—PIK3CB—ovarian cancer	5.17e-05	0.000168	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—YAP1—ovarian cancer	5.13e-05	0.000167	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—IL2—ovarian cancer	5.09e-05	0.000166	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—TERT—ovarian cancer	5.07e-05	0.000165	CbGpPWpGaD
Pethidine—ALB—Metabolism—FASN—ovarian cancer	5.06e-05	0.000165	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—APC—ovarian cancer	5.06e-05	0.000165	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PIK3CG—ovarian cancer	5.06e-05	0.000165	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—NRAS—ovarian cancer	5.06e-05	0.000165	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—BRIP1—ovarian cancer	5e-05	0.000163	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PPP1CC—ovarian cancer	5e-05	0.000163	CbGpPWpGaD
Pethidine—ALB—Platelet activation, signaling and aggregation—AKT1—ovarian cancer	5e-05	0.000163	CbGpPWpGaD
Pethidine—ALB—Metabolism—SLC5A5—ovarian cancer	4.98e-05	0.000162	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PPP2R1A—ovarian cancer	4.86e-05	0.000158	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	4.85e-05	0.000158	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—MAPK3—ovarian cancer	4.85e-05	0.000158	CbGpPWpGaD
Pethidine—ALB—Metabolism—SLC2A1—ovarian cancer	4.81e-05	0.000157	CbGpPWpGaD
Pethidine—ALB—Hemostasis—IL2—ovarian cancer	4.75e-05	0.000155	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	4.71e-05	0.000153	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CAV1—ovarian cancer	4.69e-05	0.000153	CbGpPWpGaD
Pethidine—ALB—Metabolism—CYP1B1—ovarian cancer	4.61e-05	0.00015	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—MAPK1—ovarian cancer	4.61e-05	0.00015	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—EGFR—ovarian cancer	4.61e-05	0.00015	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—FASN—ovarian cancer	4.55e-05	0.000148	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—ESR1—ovarian cancer	4.52e-05	0.000147	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—ABCB1—ovarian cancer	4.51e-05	0.000147	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—SLC5A5—ovarian cancer	4.47e-05	0.000145	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—IL6ST—ovarian cancer	4.45e-05	0.000145	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PIK3CD—ovarian cancer	4.45e-05	0.000145	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—TYMS—ovarian cancer	4.43e-05	0.000144	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—PIK3CA—ovarian cancer	4.41e-05	0.000143	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—KRAS—ovarian cancer	4.35e-05	0.000142	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—SLC2A1—ovarian cancer	4.32e-05	0.000141	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—APC—ovarian cancer	4.28e-05	0.000139	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PIK3CG—ovarian cancer	4.28e-05	0.000139	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—NRAS—ovarian cancer	4.28e-05	0.000139	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	4.23e-05	0.000138	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—FASN—ovarian cancer	4.18e-05	0.000136	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CYP1B1—ovarian cancer	4.14e-05	0.000135	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—SLC5A5—ovarian cancer	4.11e-05	0.000134	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—MAPK3—ovarian cancer	4.09e-05	0.000133	CbGpPWpGaD
Pethidine—ALB—Metabolism—PPP2R1A—ovarian cancer	4.09e-05	0.000133	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	4.07e-05	0.000132	CbGpPWpGaD
Pethidine—ALB—Hemostasis—VEGFA—ovarian cancer	4.04e-05	0.000131	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—PIK3CA—ovarian cancer	4e-05	0.00013	CbGpPWpGaD
Pethidine—ALB—Hemostasis—NRAS—ovarian cancer	3.99e-05	0.00013	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—SLC2A1—ovarian cancer	3.97e-05	0.000129	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—ERBB2—ovarian cancer	3.93e-05	0.000128	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—MAPK1—ovarian cancer	3.9e-05	0.000127	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—EGFR—ovarian cancer	3.9e-05	0.000127	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PIK3CB—ovarian cancer	3.88e-05	0.000126	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MTOR—ovarian cancer	3.88e-05	0.000126	CbGpPWpGaD
Pethidine—ALB—Hemostasis—MAPK3—ovarian cancer	3.82e-05	0.000124	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CYP1B1—ovarian cancer	3.81e-05	0.000124	CbGpPWpGaD
Pethidine—ALB—Metabolism—ABCB1—ovarian cancer	3.8e-05	0.000124	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PIK3CD—ovarian cancer	3.76e-05	0.000122	CbGpPWpGaD
Pethidine—ALB—Metabolism—TYMS—ovarian cancer	3.73e-05	0.000121	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CXCL8—ovarian cancer	3.73e-05	0.000121	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—PIK3CA—ovarian cancer	3.72e-05	0.000121	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—HRAS—ovarian cancer	3.7e-05	0.00012	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—KRAS—ovarian cancer	3.68e-05	0.00012	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	3.67e-05	0.000119	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	3.65e-05	0.000119	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CDKN1B—ovarian cancer	3.64e-05	0.000118	CbGpPWpGaD
Pethidine—ALB—Hemostasis—MAPK1—ovarian cancer	3.63e-05	0.000118	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—AKT1—ovarian cancer	3.6e-05	0.000117	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—CAV1—ovarian cancer	3.57e-05	0.000116	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CASP3—ovarian cancer	3.57e-05	0.000116	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—IL2—ovarian cancer	3.56e-05	0.000116	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—IL6—ovarian cancer	3.54e-05	0.000115	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CCND1—ovarian cancer	3.47e-05	0.000113	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CTNNB1—ovarian cancer	3.44e-05	0.000112	CbGpPWpGaD
Pethidine—ALB—Hemostasis—KRAS—ovarian cancer	3.43e-05	0.000112	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—ABCB1—ovarian cancer	3.41e-05	0.000111	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—PIK3CA—ovarian cancer	3.38e-05	0.00011	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PPP2R1A—ovarian cancer	3.38e-05	0.00011	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MMP9—ovarian cancer	3.37e-05	0.00011	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—YAP1—ovarian cancer	3.35e-05	0.000109	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PTEN—ovarian cancer	3.35e-05	0.000109	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—TYMS—ovarian cancer	3.35e-05	0.000109	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—ERBB2—ovarian cancer	3.32e-05	0.000108	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PIK3CB—ovarian cancer	3.28e-05	0.000107	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MTOR—ovarian cancer	3.28e-05	0.000107	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—AKT1—ovarian cancer	3.27e-05	0.000106	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PIK3CG—ovarian cancer	3.25e-05	0.000106	CbGpPWpGaD
Pethidine—ALB—Hemostasis—PIK3CA—ovarian cancer	3.15e-05	0.000103	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CXCL8—ovarian cancer	3.15e-05	0.000102	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—ABCB1—ovarian cancer	3.14e-05	0.000102	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—HRAS—ovarian cancer	3.13e-05	0.000102	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—TYMS—ovarian cancer	3.08e-05	0.0001	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CDKN1B—ovarian cancer	3.07e-05	0.0001	CbGpPWpGaD
Pethidine—ALB—Hemostasis—TP53—ovarian cancer	3.05e-05	9.93e-05	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—AKT1—ovarian cancer	3.04e-05	9.9e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—VEGFA—ovarian cancer	3.03e-05	9.85e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CASP3—ovarian cancer	3.01e-05	9.81e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—IL2—ovarian cancer	3.01e-05	9.79e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—CAV1—ovarian cancer	3.01e-05	9.78e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—STAT3—ovarian cancer	3e-05	9.75e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—IL6—ovarian cancer	2.99e-05	9.74e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—NRAS—ovarian cancer	2.99e-05	9.72e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CCND1—ovarian cancer	2.93e-05	9.54e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—HRAS—ovarian cancer	2.92e-05	9.5e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CTNNB1—ovarian cancer	2.9e-05	9.45e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.87e-05	9.34e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MAPK3—ovarian cancer	2.86e-05	9.31e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PIK3CD—ovarian cancer	2.86e-05	9.3e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MMP9—ovarian cancer	2.85e-05	9.27e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PTEN—ovarian cancer	2.83e-05	9.21e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MYC—ovarian cancer	2.78e-05	9.06e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—AKT1—ovarian cancer	2.76e-05	8.99e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PIK3CG—ovarian cancer	2.74e-05	8.91e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—FASN—ovarian cancer	2.73e-05	8.89e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MAPK1—ovarian cancer	2.72e-05	8.86e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—EGFR—ovarian cancer	2.72e-05	8.86e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CAV1—ovarian cancer	2.7e-05	8.78e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—SLC5A5—ovarian cancer	2.69e-05	8.75e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—SLC2A1—ovarian cancer	2.6e-05	8.45e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.58e-05	8.39e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—AKT1—ovarian cancer	2.58e-05	8.38e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—KRAS—ovarian cancer	2.57e-05	8.37e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—VEGFA—ovarian cancer	2.56e-05	8.32e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—STAT3—ovarian cancer	2.53e-05	8.24e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—NRAS—ovarian cancer	2.53e-05	8.22e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PIK3CB—ovarian cancer	2.49e-05	8.11e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CYP1B1—ovarian cancer	2.49e-05	8.1e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CAV1—ovarian cancer	2.48e-05	8.08e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PIK3CG—ovarian cancer	2.46e-05	8e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MAPK3—ovarian cancer	2.42e-05	7.87e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PIK3CD—ovarian cancer	2.41e-05	7.83e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PIK3CA—ovarian cancer	2.36e-05	7.69e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MYC—ovarian cancer	2.35e-05	7.66e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MAPK1—ovarian cancer	2.3e-05	7.49e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—EGFR—ovarian cancer	2.3e-05	7.49e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—TP53—ovarian cancer	2.29e-05	7.44e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PIK3CG—ovarian cancer	2.26e-05	7.36e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	2.21e-05	7.19e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—HRAS—ovarian cancer	2.19e-05	7.11e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—KRAS—ovarian cancer	2.17e-05	7.07e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PIK3CD—ovarian cancer	2.16e-05	7.03e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PTEN—ovarian cancer	2.15e-05	7.01e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PIK3CB—ovarian cancer	2.1e-05	6.83e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—IL6—ovarian cancer	2.09e-05	6.81e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ABCB1—ovarian cancer	2.05e-05	6.67e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—TYMS—ovarian cancer	2.01e-05	6.55e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PIK3CA—ovarian cancer	2e-05	6.5e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PIK3CD—ovarian cancer	1.99e-05	6.47e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—TP53—ovarian cancer	1.93e-05	6.29e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—AKT1—ovarian cancer	1.93e-05	6.28e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PIK3CB—ovarian cancer	1.88e-05	6.13e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—HRAS—ovarian cancer	1.85e-05	6.01e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PTEN—ovarian cancer	1.81e-05	5.9e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—IL6—ovarian cancer	1.77e-05	5.75e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PIK3CB—ovarian cancer	1.73e-05	5.64e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—AKT1—ovarian cancer	1.63e-05	5.31e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PTEN—ovarian cancer	1.63e-05	5.3e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CAV1—ovarian cancer	1.62e-05	5.28e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PIK3CA—ovarian cancer	1.52e-05	4.94e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PTEN—ovarian cancer	1.5e-05	4.87e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PIK3CG—ovarian cancer	1.48e-05	4.81e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PIK3CD—ovarian cancer	1.3e-05	4.23e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PIK3CA—ovarian cancer	1.28e-05	4.16e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—AKT1—ovarian cancer	1.24e-05	4.04e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PIK3CA—ovarian cancer	1.15e-05	3.74e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PIK3CB—ovarian cancer	1.13e-05	3.68e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PIK3CA—ovarian cancer	1.06e-05	3.44e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—AKT1—ovarian cancer	1.04e-05	3.4e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PTEN—ovarian cancer	9.79e-06	3.18e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—AKT1—ovarian cancer	9.38e-06	3.05e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—AKT1—ovarian cancer	8.63e-06	2.81e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PIK3CA—ovarian cancer	6.9e-06	2.25e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—AKT1—ovarian cancer	5.64e-06	1.84e-05	CbGpPWpGaD
